Virax Biolabs receives Nasdaq letter over non-compliance with minimum bid price rule

* Virax Biolabs Group (NASDAQ:VRAX [https://seekingalpha.com/symbol/VRAX]) received a notice from Nasdaq notifying the company that it is not in compliance with its minimum bid price requirement.
* The company has a compliance period of one hundred eighty (180) calendar days, or until January 12, 2026 to regain compliance with Nasdaq's minimum bid price requirement
* Source: Press Release [https://seekingalpha.com/pr/20171134-virax-biolabs-announces-receipt-of-nasdaq-notification-letter-regarding-minimum-bid-price]

MORE ON VIRAX BIOLABS GROUP LIMITED

* Seeking Alpha’s Quant Rating on Virax Biolabs Group Limited [https://seekingalpha.com/symbol/VRAX/ratings/quant-ratings]
* Financial information for Virax Biolabs Group Limited [https://seekingalpha.com/symbol/VRAX/income-statement]